Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive anti-reflux therapy

American Journal of Gastroenterology

Volumn 91, Issue 10, 1996, Pages 2110-2113

  Katzka, David A ^a   Paoletti, Vera ^a   Leite, Louis ^a   Castell, Donald O ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

AMBULATORY MONITORING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; PATIENT SELECTION; PH MEASUREMENT; PRIORITY JOURNAL; TREATMENT INDICATION;

DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MONITORING, AMBULATORY; OMEPRAZOLE; PROTON PUMPS; TIME FACTORS;

EID: 0029821732     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. Am J Gastroenterol 1974;62:325-32.
2. DeMeester TR, Johnson LF, Joseph GJ, et al. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976;184:459-69.
3. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995;155:2165-73.
4. Klinkenberg-Knol EC, Meuwissen SGM. Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990;4:485-90.
5. Klinkenberg-Knol EC, Festen HPM, Jansen JBM, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety. Ann Intern Med 1994;121:161-7.
6. Kuo B, Castell DO. Omeprazole 20 mg bid provides better acid suppression than a single dose of 40 mg. Gastroenterology 1994;106: A1034 (abstract).
7. Wiener GJ, Richter JE, Cooper JB, et al. The symptom index: A clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988;83:358-61.
8. Simpson WG. Gastroesophageal reflux disease and asthma: Diagnosis and management. Arch Intern Med 1995;155:798-803.
9. Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995;104:550-5.
10. Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995;109:1575-82.
11. Bracy NA, Gideon RM, Castell DO. Duration of gastric acid suppression by omeprazole on normal subjects is highly variable. Am J Gastroenterol 1995;108:A62.